BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 172 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,000 | -98.0% | 200 | -99.2% | 0.00% | -100.0% |
| Q1 2020 | $49,000 | +250.0% | 24,433 | +581.2% | 0.00% | +200.0% |
| Q2 2019 | $14,000 | +40.0% | 3,587 | +172.2% | 0.00% | 0.0% |
| Q3 2018 | $10,000 | +42.9% | 1,318 | +64.8% | 0.00% | 0.0% |
| Q1 2017 | $7,000 | -90.0% | 800 | -96.8% | 0.00% | -90.0% |
| Q2 2016 | $70,000 | +311.8% | 24,700 | +311.7% | 0.01% | +400.0% |
| Q1 2016 | $17,000 | +142.9% | 6,000 | +650.0% | 0.00% | +100.0% |
| Q1 2015 | $7,000 | -87.3% | 800 | -82.2% | 0.00% | -87.5% |
| Q4 2014 | $55,000 | +71.9% | 4,500 | +36.4% | 0.01% | +60.0% |
| Q3 2014 | $32,000 | -3.0% | 3,300 | +26.9% | 0.01% | +25.0% |
| Q2 2014 | $33,000 | – | 2,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 6,071,142 | $50,998,000 | 20.86% |
| RTW INVESTMENTS, LP | 3,458,120 | $29,048,000 | 7.65% |
| ISZO CAPITAL MANAGEMENT LP | 307,366 | $2,582,000 | 4.49% |
| DAFNA Capital Management LLC | 541,128 | $4,545,000 | 3.84% |
| RA Capital Management | 3,489,795 | $29,314,000 | 3.60% |
| EMORY UNIVERSITY | 375,348 | $3,153,000 | 2.98% |
| Ghost Tree Capital, LLC | 1,500,000 | $12,600,000 | 2.35% |
| ACUTA CAPITAL PARTNERS, LLC | 920,310 | $7,731,000 | 1.83% |
| Avoro Capital Advisors LLC | 1,603,001 | $13,465,000 | 1.72% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,085,236 | $25,916,000 | 1.00% |